Search Results - "VAN TIENHOVEN, G"

Meta‐analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer by Versteijne, E., Vogel, J. A., Besselink, M. G., Busch, O. R. C., Wilmink, J. W., Daams, J. G., van Eijck, C. H. J., Groot Koerkamp, B., Rasch, C. R. N., van Tienhoven, G.

“…Background Studies comparing upfront surgery with neoadjuvant treatment in pancreatic cancer may report only patients who underwent resection and so survival…”
Get full text

Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial by Janssen, Q P, van Dam, J L, Bonsing, B A, Bos, H, Bosscha, K P, Coene, P P L O, van Eijck, C H J, de Hingh, I H J T, Karsten, T M, van der Kolk, M B, Patijn, G A, Liem, M S L, van Santvoort, H C, Loosveld, O J L, de Vos-Geelen, J, Zonderhuis, B M, Homs, M Y V, van Tienhoven, G, Besselink, M G, Wilmink, J W, Groot Koerkamp, B

“…Neoadjuvant therapy has several potential advantages over upfront surgery in patients with localized pancreatic cancer; more patients receive systemic…”
Get full text

Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience by Rassam, F., Roos, E., van Lienden, K. P., van Hooft, J. E., Klümpen, H. J., van Tienhoven, G., Bennink, R. J., Engelbrecht, M. R., Schoorlemmer, A., Beuers, U. H. W., Verheij, J., Besselink, M. G., Busch, O. R., van Gulik, T. M.

“…Aim Perihilar cholangiocarcinoma (PHC) is a challenging disease and requires aggressive surgical treatment in order to achieve curation. The assessment and…”
Get full text

Treatment and prognostic factors of radiation-associated angiosarcoma (RAAS) after primary breast cancer: A systematic review by Depla, A.L, Scharloo-Karels, C.H, de Jong, M.A.A, Oldenborg, S, Kolff, M.W, Oei, S.B, van Coevorden, F, van Rhoon, G.C, Baartman, E.A, Scholten, R.J, Crezee, J, van Tienhoven, G

“…Abstract Background Radiation-associated angiosarcoma (RAAS) of the breast is a rare, aggressive disease. The incidence is increasing with the prolonged…”
Get full text

Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy by Van der Kwast, T, Al Daoud, N, Collette, L, Sykes, J, Thoms, J, Milosevic, M, Bristow, R.G, Van Tienhoven, G, Warde, P, Mirimanoff, R.-O, Bolla, M

“…Abstract Aim We investigated the prognostic significance of intraductal carcinoma of the prostate (IDC-P) in biopsies and transurethral resections prior to…”
Get full text

New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel by Van Laethem, J.-L., Verslype, C., Iovanna, J.L., Michl, P., Conroy, T., Louvet, C., Hammel, P., Mitry, E., Ducreux, M., Maraculla, T., Uhl, W., Van Tienhoven, G., Bachet, J.B., Maréchal, R., Hendlisz, A., Bali, M., Demetter, P., Ulrich, F., Aust, D., Luttges, J., Peeters, M., Mauer, M., Roth, A., Neoptolemos, J.P., Lutz, M.

“…Although the treatment of pancreatic ductal adenocarcinoma (PDAC) remains a huge challenge, it is entering a new era with the development of new strategies and…”
Get full text

Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design by Doppenberg, D, Besselink, M G, van Eijck, C H J, Intven, M P W, Koerkamp, B Groot, Kazemier, G, van Laarhoven, H W M, Meijerink, M, Molenaar, I Q, Nuyttens, J J M E, van Os, R, van Santvoort, H C, van Tienhoven, G, Verkooijen, H M, Versteijne, E, Wilmink, J W, Lagerwaard, F J, Bruynzeel, A M E

“…Significant comorbidities, advanced age, and a poor performance status prevent surgery and systemic treatment for many patients with localized (non-metastatic)…”
Get full text

Quantifying the reduction of respiratory motion by mechanical ventilation with MRI for radiotherapy by van Kesteren, Z, Veldman, J K, Parkes, M J, Stevens, M F, Balasupramaniam, P, van den Aardweg, J G, van Tienhoven, G, Bel, A, van Dijk, I W E M

“…Due to respiratory motion, accurate radiotherapy delivery to thoracic and abdominal tumors is challenging. We aimed to quantify the ability of mechanical…”
Get full text

Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design by Doppenberg, D, Besselink, M G, van Eijck, C H J, Intven, M P W, Groot Koerkamp, B, Kazemier, G, van Laarhoven, H W M, Meijerink, M, Molenaar, I Q, Nuyttens, J J M E, van Os, R, van Santvoort, H C, van Tienhoven, G, Verkooijen, H M, Versteijne, E, Wilmink, J W, Lagerwaard, F J, Bruynzeel, A M E

Get full text

A novel amplitude binning strategy to handle irregular breathing during 4DMRI acquisition: improved imaging for radiotherapy purposes by van Kesteren, Z, van der Horst, A, Gurney-Champion, O J, Bones, I, Tekelenburg, D, Alderliesten, T, van Tienhoven, G, Klaassen, R, van Laarhoven, H W M, Bel, A

“…For radiotherapy of abdominal cancer, four-dimensional magnetic resonance imaging (4DMRI) is desirable for tumor definition and the assessment of tumor and…”
Get full text

Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort by Doppenberg, D, Lagerwaard, F J, van Dieren, S, Meijerink, M R, van der Vliet, J J, Besselink, M G, van Tienhoven, G, Versteijne, E, Slotman, B J, Wilmink, J W, Kazemier, G, Bruynzeel, A M E

“…The role of stereotactic ablative radiation therapy (SABR) as local treatment option after chemotherapy for locally advanced pancreatic cancer (LAPC) is…”
Get full text

A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE) by van Goor, I W J M, Daamen, L A, Besselink, M G, Bruynzeel, A M E, Busch, O R, Cirkel, G A, Groot Koerkamp, B, Haj Mohammed, N, Heerkens, H D, van Laarhoven, H W M, Meijer, G J, Nuyttens, J, van Santvoort, H C, van Tienhoven, G, Verkooijen, H M, Wilmink, J W, Molenaar, I Q, Intven, M P W

“…Disease recurrence is the main cause of mortality after resection of pancreatic ductal adenocarcinoma (PDAC). In 20-30% of resected patients, isolated local…”
Get full text

Correction: Quantifying the reduction of respiratory motion by mechanical ventilation with MRI for radiotherapy by van Kesteren, Z, Veldman, J. K, Parkes, M. J, Stevens, M. F, Balasupramaniam, P, van den Aardweg, J. G, van Tienhoven, G, Bel, A, van Dijk, I. W. E. M

Get full text

Correction: A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE) by van Goor, I W J M, Daamen, L A, Besselink, M G, Bruynzeel, A M E, Busch, O R, Cirkel, G A, Koerkamp, B Groot, Mohammed, N Haj, Heerkens, H D, van Laarhoven, H W M, Meijer, G J, Nuyttens, J, van Santvoort, H C, van Tienhoven, G, Verkooijen, H M, Wilmink, J W, Molenaar, I Q, Intven, M P W

Get full text

Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of 6% Miltefosine Solution, a Topical Chemotherapy in Cutaneous Metastases From Breast Cancer by LEONARD, R, HARDY, J, VAN TIENHOVEN, G, HOUSTON, S, SIMMONDS, P, DAVID, M, MANSI, J

“…To compare 6% miltefosine solution (Miltex; Asta Medica, Frankfurt, Germany), a new topical cytostatic drug, with placebo as palliative treatment for cutaneous…”
Get full text

Fatigue and radiotherapy: (A) experience in patients undergoing treatment by SMETS, E. M. A, VISSER, M. R. M, WILLEMS-GROOT, A. F. M. N, GARSSEN, B, OLDENBURGER, F, VAN TIENHOVEN, G, DE HAES, J. C. J. M

“…Cancer patients undergoing radiotherapy frequently report fatigue. However, knowledge of the importance of fatigue for these patients and of the factors…”
Get full text

Determining the indications for post mastectomy radiotherapy: moving from 20th century clinical staging to 21st century biological criteria by Russell, N.S., Kunkler, I.H., van Tienhoven, G.

Get full text

Patterns of practice of regional nodal irradiation in breast cancer: results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal Radiotherapy (NORA) survey by Belkacemi, Y., Kaidar-Person, O., Poortmans, P., Ozsahin, M., Valli, M-C., Russell, N., Kunkler, I., Hermans, J., Kuten, A., van Tienhoven, G., Westenberg, H.

“…Predicting breast cancer outcome based on SLN node status without ALND is currently an area of uncertainty in SLN+ patients. These uncertainties influence the…”
Get full text

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) by Gourgou-Bourgade, S., Cameron, D., Poortmans, P., Asselain, B., Azria, D., Cardoso, F., A'Hern, R., Bliss, J., Bogaerts, J., Bonnefoi, H., Brain, E., Cardoso, M.J., Chibaudel, B., Coleman, R., Cufer, T., Dal Lago, L., Dalenc, F., De Azambuja, E., Debled, M., Delaloge, S., Filleron, T., Gligorov, J., Gutowski, M., Jacot, W., Kirkove, C., MacGrogan, G., Michiels, S., Negreiros, I., Offersen, B.V., Penault Llorca, F., Pruneri, G., Roche, H., Russell, N.S., Schmitt, F., Servent, V., Thürlimann, B., Untch, M., van der Hage, J.A., van Tienhoven, G., Wildiers, H., Yarnold, J., Bonnetain, F., Mathoulin-Pélissier, S., Bellera, C., Dabakuyo-Yonli, T.S.

Get full text

Preoperative chemoradiotherapy diminishes the risk of postoperative pancreatic fistula after pancreatoduodenectomy by Wismans, L., Suurmeijer, A., Van Dongen, J., Busch, O., Bonsing, B., Van Santvoort, H., Koerkamp, B. Groot, Wilmink, H., Van Tienhoven, G., Besselink, M., Van Eijck, C.

Get full text